Process for production of naphthyridine-3-carboxylic acid...

Details Process for production of naphthyridine-3-carboxylic acid... Process for production of naphthyridine-3-carboxylic acid...

2007-06-19

2007-06-19

Saeed, Kamal A. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

10692640

ABSTRACT:
A process for the production of naphthyridine-3-carboxylic acid derivatives of formula (I) having antibacterial activity.

REFERENCES:
patent: 5633262 (1997-05-01), Hong et al.
patent: 5776944 (1998-07-01), Hong et al.
patent: 5869670 (1999-02-01), Hong et al.
patent: 5962468 (1999-10-01), Hong et al.
patent: 6307059 (2001-10-01), Chang et al.
patent: 0 058 614 (1982-08-01), None
patent: 0 183 129 (1986-06-01), None
patent: 0 266 576 (1988-05-01), None
patent: 0 183 129 (1989-08-01), None
patent: 0 326 891 (1989-08-01), None
patent: 0 541 086 (1993-05-01), None
patent: 0 688 772 (1995-12-01), None
patent: 0 688 772 (1995-12-01), None
patent: 0 805 156 (1997-11-01), None
patent: 0 688 772 (1999-05-01), None
patent: 01 100165 (1989-04-01), None
patent: 03 056479 (1991-03-01), None
patent: 06-73056 (1994-03-01), None
patent: WO 91/02526 (1991-03-01), None
patent: WO 92/10191 (1992-06-01), None
patent: WO 96/39406 (1996-12-01), None
patent: WO 97/07098 (1997-02-01), None
patent: WO 97/36874 (1997-10-01), None
patent: WO 98 42705 (1998-10-01), None
patent: WO 98/42705 (1998-10-01), None
patent: WO 99/44991 (1999-09-01), None
patent: WO 99/61420 (1999-12-01), None
patent: WO 00/17199 (2000-03-01), None
patent: WO 01/00209 (2001-01-01), None
patent: WO 01/15695 (2001-03-01), None
patent: WO 01/17961 (2001-03-01), None
patent: WO 01/18002 (2001-03-01), None
patent: WO 01/21176 (2001-03-01), None
patent: WO 01/68649 (2001-09-01), None
patent: WO 02/18336 (2002-03-01), None
M-J. Ahn, et al., “Effect of a New Fluoroquinolone LB20304a on Microflora of Caecum in Mice”, Yakhak Hoeji (Yakhak Hoechi) vol. 40, No. 3, pp. 343-346 (1996).
M-J. Ahn, et al, “Post-Antibiotic Effect of LB20304, A New Quinolone Antibiotic”, Yakhak Hoeji (Yakhak Hoechi) vol. 40, No. 3, pp. 347-350 (1996).
M-J. Ahn, et al., “InVivo Efficacy of LB20304a against Experimental Respiratory Tract Infection in Mice”, Yakhak Hoeji (Yakhak Hoechi) vol. 40, No. 4, pp. 438-441 (1996).
CS Cooper et al, J. Med. Chem, 35, 1992, 1392-1398.
G. Cormican, “Comparative Antimicrobial and Spectrum Activity of LB20304a, a New Fluoronated Naphthyridone Compound”,Abstracts of the 36th ICAAC, 109 Abst F53 (1996).
MG Cormican et al, “Antimicrobial Activity and Spectrum of LB20304, a novel Fluoronaphthyridone”,Antimicrobial Agents and Chemotherapy, Jan. 1997, 41, 204-211.
JM Domagala et al, J. Med. Chem., 31, 1988, 991-1001.
JM Domagala et al, J. Med. Chem., 34, 1991, 1142-1154.
C. Yong Hong, et al., “Novel Fluoroquinolone Antibacterial Agents Containing Oxime-Substituted (Aminomethyl) pyrrolidines: Synthesis and Antibacterial Activity of 7-(4-(Aminomethyl)-3-(methoxyimino) pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro [1,8] naphthyridine-3-carboxylic Acid (LB20304)”,J. Med. Chem., 40(22), pp. 3584-3593 (1997).
M-Y Kim et al., “In vitro activities of LB20304, a new Fluoroquinolone”,Arch. Pharm. Res., 1996, 19(1), 52-59.
J-H. Kwak, “Antimicrobial Activities of LB20304a, a New Quinolone Antibiotic”,The Journal of Applied Pharmacology(4) pp. 378-384 (1996).
F. Marco, et al., Äntimicrobial Activity of LB20304, a Fluoronaphthyridone, Tested Against Anaerobic Bacteria,J. Antimicrobial Chemothervol. 40, No. 4, pp. 605-607 (1997).
J-I Oh et al, “In vitro and in vivo evaluations of LB20304, a new Fluoroquinolone”,Antimicrobial Agents and Chemotherapy, Jun. 1996, 40(6), 1564-1568.
K.-S. Paek et al., “Factors effecting in vitro activity of LB20304, a new fluoroquinolone”,Arch. Pharm. Res., 1996, 19(2), 143-147.
K.-S. Paek et al., “Bactericidal activities of LB20304, a new Fluoroquinolone”,Arch. Pharm. Res., 1996, 19(4), 317-320.
M-K. Seo, “Pharmacokinetics of LB20304, a New Fluoroquinolone, in Rats and Dogs”,Arch. Pharm. Res. vol. 19, No. 5, pp. 359-367 (1996).
M-K. Seo et al., “High Performance Liquid Chromatographic Assay of a New Fluoroquinolone, LB20304, in the Plasma of Rats and Dogs”,Arch. Pharm. Res. vol. 19, No. 6, pp. 554-558 (1996).
Patent Abstracts of Japan, vol. 015, No. 202 (C-0834), May 23, 1991 (JP03056479A, Mar. 12, 1991).
SB-265805, A Potent New Quinolone, 38th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, ICAAC, San Diego Convention Centre, 105-F Poster Session, New Fluoroquinolones II, Sep. 26th 1998: cover page, contents page and Abstract Nos. F-087 through F-106.

Affiliated with

Also associated with

Rating

Process for production of naphthyridine-3-carboxylic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for production of naphthyridine-3-carboxylic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for production of naphthyridine-3-carboxylic acid... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3814107